Core Scientific, Inc. (CORZ) is a Software - Infrastructure company in the Technology sector, currently trading at $18.68. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CORZ = $688.77 (+3587.2% from the current price, the stock appears undervalued). Analyst consensus target is CORZ = $26 (+40.3% upside).
Valuation: CORZ trades at a trailing Price-to-Earnings (P/E) of -19.8 (S&P 500 average ~25).
Financials: revenue is $319M, -19.1%/yr average growth. Net income is $289M (loss), growing at -89%/yr. Net profit margin is -90.5% (negative). Gross margin is 11.9% (+10.6 pp trend).
Balance sheet: total debt is $1.1B with negative equity of -$963M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.15 (adequate). Debt-to-assets is 45.2%. Total assets: $2.3B.
Analyst outlook: 19 / 22 analysts rate CORZ as buy (86%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 25/100 (Fail), Moat 42/100 (Fail), Future 94/100 (Pass), Income 10/100 (Fail).
